Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

First Patient-centric Point-of-Care (POC) Marketing Analytics Solution Significantly Increases Accuracy of Campaign Measurement

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/03/2013 | 05:01am EST

Crossix Solutions' exclusive patient-centered approach breaks the long-standing physician data ceiling

Doctor's offices, where patients are primed to receive healthcare information, are a fast-growing point-of-care (POC) marketing channel, for everything from unbranded disease education to branded product advertising. However, traditional POC campaign measurement has been physician-centric, making it difficult to accurately measure patient impact and impossible to benchmark against other direct-to-consumer vehicles. Crossix Solutions' latest analytics innovation, Crossix POC Impact TM, now enables marketers to go beyond prescriber data and capture patient impact for a true representation of campaign effectiveness.

"Crossix's patient-centric campaign analytics are a valuable addition to the measurement tool-kit at the point-of-care," said Dan Stone, co-chair of the Point of Care Communication Council (PoC3) and CEO of AccentHealth, America's largest point-of-care TV network. "With the Crossix methodology, a campaign's impact can be measured versus other POC tactics and relative to other direct-to-consumer channels."

Crossix POC Impact is part of the company's suite of privacy-safe campaign analytics and optimization solutions, and uses a consistent methodology that enables comparisons across tactics and channels within the broader DTC marketing mix. POC Impact has quickly gained traction throughout the industry, as more than a dozen marketing agencies and pharmaceutical companies have captured revealing campaign analytics with the new solution. Crossix also provides and has published POC campaign benchmarks, enabling marketers to compare their campaigns' performance against market norms.

"POC campaigns have the power to influence patient conversion and adherence, which makes accurate measurement crucial," said Asaf Evenhaim, CEO and co-founder of Crossix, who presented at the inaugural Point of Care National conference last month. "Our patient-centered solution is a breakthrough in marketing analytics, and - for the first time - empowers POC marketers and brand managers to accurately determine ROI, by capturing critical data missed by other methods that estimate impact based on physician prescribing behavior alone."

Crossix POC Impact also allows healthcare marketers to measure:

  • Incremental purchases of prescription (Rx) and over-the-counter (OTC) medications, at both the individual and household level
  • Specific tactics within POC programs, such as in-office TV, wallboards, patient brochures, co-pay offer distribution, and more
  • Impact of campaigns in concert with non-POC initiatives
  • Performance of pharmacy marketing programs

"Traditional measurement approaches have undervalued the true impact of the POC channel," added Tom McGuinness, co-chair of the Point of Care Communication Council (PoC3) and CEO of PatientPoint, a leading provider of patient and physician engagement solutions at the point of care. "This patient-focused approach helps our clients understand the full impact of their campaigns, and expands beyond Rx implications to measure campaigns more broadly, from an OTC and CPG perspective."

To learn more about Crossix POC Impact TM, go directly to http://crossix.com/crossix-poc-impact.

In related news, Crossix has been named the first Affiliate Member of the Point of Care Communication Council (PoC3) founded earlier this year. The Council represents healthcare media and information service companies at the point-of-care, including physician office, hospital and pharmacy venues and with members that include industry leaders AccentHealth, PatientPoint, ContextMedia and WebMD, among others. More information at http://poc3.org.

About Crossix Solutions

As the only company founded and focused on a consumer-centric healthcare analytics approach, Crossix is the industry standard by which Top 10 Pharma companies and leading agencies & publishers plan, measure and optimize consumer marketing initiatives. Crossix offers the most complete cross-channel solutions, helping marketers by correlating campaign exposure to increased sales. Crossix quickly analyzes data, offers forward-looking strategic guidance, and follows through with recommendations to optimize. Leveraging trends in "Big Data," and by partnering with some of the most respected names in the industry, Crossix helps marketers get marketing messages to the desired audience. The Crossix patented methodology incorporates best-in-class privacy safeguards far exceeding HIPAA regulations. Founded in 2004, Crossix is headquartered in New York City. For more, visit www.crossix.com.

© 2013 Crossix Solutions Inc. All rights reserved. Crossix and the Crossix logo are trademarks of Crossix Solutions Inc.

All other trademarks appearing in this Press Release are the property of their respective owners and no association, affiliation, sponsorship or endorsement by those owners is either intended or implied.

Crossix Solutions
Lisa Barbadora, 610-420-3413
pr@crossix.com


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
06:17pELLINGTON FINANCIAL : Declares Monthly Dividend of $0.14 Per Common Share and Announces Estimated Book Value Per Common Share of $18.51 as of November 30, 2019
BU
06:15pREGIONS FINANCIAL :  Regions Financial Corporation Announces Results of Tender Offer for 3.200% Senior Notes due 2021
BU
06:12pERICSSON : agrees to pay over $1 billion to resolve U.S. corruption probe
RE
06:09pTESLA : boss Elon Musk wins defamation trial over 'pedo guy' tweet
RE
06:06pELON MUSK : Tesla boss Elon Musk wins defamation trial over 'pedo guy' tweet
RE
06:06pCHANGE - CHANGE IN CORPORATE INFORMATION : :Striking Off and Voluntary Liquidation of Subsidiaries
PU
06:02pPomerantz Law Firm Investigates Claims on Behalf of Investors of Correvio Pharma Corporation – CORV
GL
06:01pFURA GEMS : Announces Update on Australian Sapphire Mining Project Acquisition
AQ
06:01pDELTA 9 CANNABIS : Receives Extract Sales Authorization from Health Canada
AQ
06:01pGLANCY PRONGAY & MURRAY LLP : Continues its Investigation on Behalf of Brooks Automation, Inc. Investors
BU
Latest news "Companies"